Copyright Reports & Markets. All rights reserved.

Global Lateral Flow Rapid Testing Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Lateral Flow Rapid Testing Market Size 2017-2028
    • 2.1.2 Lateral Flow Rapid Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Lateral Flow Rapid Testing Segment by Type
    • 2.2.1 Sandwich Immunoassay
    • 2.2.2 Competitive Immunoassay
  • 2.3 Lateral Flow Rapid Testing Market Size by Type
    • 2.3.1 Lateral Flow Rapid Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Lateral Flow Rapid Testing Market Size Market Share by Type (2017-2022)
  • 2.4 Lateral Flow Rapid Testing Segment by Application
    • 2.4.1 Hospitals
    • 2.4.2 Specialty Clinics
    • 2.4.3 Diagnostic Centers
    • 2.4.4 Others
  • 2.5 Lateral Flow Rapid Testing Market Size by Application
    • 2.5.1 Lateral Flow Rapid Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Lateral Flow Rapid Testing Market Size Market Share by Application (2017-2022)

3 Lateral Flow Rapid Testing Market Size by Player

  • 3.1 Lateral Flow Rapid Testing Market Size Market Share by Players
    • 3.1.1 Global Lateral Flow Rapid Testing Revenue by Players (2020-2022)
    • 3.1.2 Global Lateral Flow Rapid Testing Revenue Market Share by Players (2020-2022)
  • 3.2 Global Lateral Flow Rapid Testing Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Lateral Flow Rapid Testing by Regions

  • 4.1 Lateral Flow Rapid Testing Market Size by Regions (2017-2022)
  • 4.2 Americas Lateral Flow Rapid Testing Market Size Growth (2017-2022)
  • 4.3 APAC Lateral Flow Rapid Testing Market Size Growth (2017-2022)
  • 4.4 Europe Lateral Flow Rapid Testing Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Lateral Flow Rapid Testing Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Lateral Flow Rapid Testing Market Size by Country (2017-2022)
  • 5.2 Americas Lateral Flow Rapid Testing Market Size by Type (2017-2022)
  • 5.3 Americas Lateral Flow Rapid Testing Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Lateral Flow Rapid Testing Market Size by Region (2017-2022)
  • 6.2 APAC Lateral Flow Rapid Testing Market Size by Type (2017-2022)
  • 6.3 APAC Lateral Flow Rapid Testing Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Lateral Flow Rapid Testing by Country (2017-2022)
  • 7.2 Europe Lateral Flow Rapid Testing Market Size by Type (2017-2022)
  • 7.3 Europe Lateral Flow Rapid Testing Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Lateral Flow Rapid Testing by Region (2017-2022)
  • 8.2 Middle East & Africa Lateral Flow Rapid Testing Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Lateral Flow Rapid Testing Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Lateral Flow Rapid Testing Market Forecast

  • 10.1 Global Lateral Flow Rapid Testing Forecast by Regions (2023-2028)
    • 10.1.1 Global Lateral Flow Rapid Testing Forecast by Regions (2023-2028)
    • 10.1.2 Americas Lateral Flow Rapid Testing Forecast
    • 10.1.3 APAC Lateral Flow Rapid Testing Forecast
    • 10.1.4 Europe Lateral Flow Rapid Testing Forecast
    • 10.1.5 Middle East & Africa Lateral Flow Rapid Testing Forecast
  • 10.2 Americas Lateral Flow Rapid Testing Forecast by Country (2023-2028)
    • 10.2.1 United States Lateral Flow Rapid Testing Market Forecast
    • 10.2.2 Canada Lateral Flow Rapid Testing Market Forecast
    • 10.2.3 Mexico Lateral Flow Rapid Testing Market Forecast
    • 10.2.4 Brazil Lateral Flow Rapid Testing Market Forecast
  • 10.3 APAC Lateral Flow Rapid Testing Forecast by Region (2023-2028)
    • 10.3.1 China Lateral Flow Rapid Testing Market Forecast
    • 10.3.2 Japan Lateral Flow Rapid Testing Market Forecast
    • 10.3.3 Korea Lateral Flow Rapid Testing Market Forecast
    • 10.3.4 Southeast Asia Lateral Flow Rapid Testing Market Forecast
    • 10.3.5 India Lateral Flow Rapid Testing Market Forecast
    • 10.3.6 Australia Lateral Flow Rapid Testing Market Forecast
  • 10.4 Europe Lateral Flow Rapid Testing Forecast by Country (2023-2028)
    • 10.4.1 Germany Lateral Flow Rapid Testing Market Forecast
    • 10.4.2 France Lateral Flow Rapid Testing Market Forecast
    • 10.4.3 UK Lateral Flow Rapid Testing Market Forecast
    • 10.4.4 Italy Lateral Flow Rapid Testing Market Forecast
    • 10.4.5 Russia Lateral Flow Rapid Testing Market Forecast
  • 10.5 Middle East & Africa Lateral Flow Rapid Testing Forecast by Region (2023-2028)
    • 10.5.1 Egypt Lateral Flow Rapid Testing Market Forecast
    • 10.5.2 South Africa Lateral Flow Rapid Testing Market Forecast
    • 10.5.3 Israel Lateral Flow Rapid Testing Market Forecast
    • 10.5.4 Turkey Lateral Flow Rapid Testing Market Forecast
    • 10.5.5 GCC Countries Lateral Flow Rapid Testing Market Forecast
  • 10.6 Global Lateral Flow Rapid Testing Forecast by Type (2023-2028)
  • 10.7 Global Lateral Flow Rapid Testing Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Mologic
    • 11.1.1 Mologic Company Information
    • 11.1.2 Mologic Lateral Flow Rapid Testing Product Offered
    • 11.1.3 Mologic Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Mologic Main Business Overview
    • 11.1.5 Mologic Latest Developments
  • 11.2 Thermo Fisher Scientific
    • 11.2.1 Thermo Fisher Scientific Company Information
    • 11.2.2 Thermo Fisher Scientific Lateral Flow Rapid Testing Product Offered
    • 11.2.3 Thermo Fisher Scientific Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Thermo Fisher Scientific Main Business Overview
    • 11.2.5 Thermo Fisher Scientific Latest Developments
  • 11.3 Bio-Rad Laboratories
    • 11.3.1 Bio-Rad Laboratories Company Information
    • 11.3.2 Bio-Rad Laboratories Lateral Flow Rapid Testing Product Offered
    • 11.3.3 Bio-Rad Laboratories Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Bio-Rad Laboratories Main Business Overview
    • 11.3.5 Bio-Rad Laboratories Latest Developments
  • 11.4 Svar Life Science
    • 11.4.1 Svar Life Science Company Information
    • 11.4.2 Svar Life Science Lateral Flow Rapid Testing Product Offered
    • 11.4.3 Svar Life Science Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Svar Life Science Main Business Overview
    • 11.4.5 Svar Life Science Latest Developments
  • 11.5 Abbott Laboratories
    • 11.5.1 Abbott Laboratories Company Information
    • 11.5.2 Abbott Laboratories Lateral Flow Rapid Testing Product Offered
    • 11.5.3 Abbott Laboratories Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Abbott Laboratories Main Business Overview
    • 11.5.5 Abbott Laboratories Latest Developments
  • 11.6 Roche
    • 11.6.1 Roche Company Information
    • 11.6.2 Roche Lateral Flow Rapid Testing Product Offered
    • 11.6.3 Roche Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Roche Main Business Overview
    • 11.6.5 Roche Latest Developments
  • 11.7 Danaher
    • 11.7.1 Danaher Company Information
    • 11.7.2 Danaher Lateral Flow Rapid Testing Product Offered
    • 11.7.3 Danaher Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Danaher Main Business Overview
    • 11.7.5 Danaher Latest Developments
  • 11.8 Siemens Healthcare
    • 11.8.1 Siemens Healthcare Company Information
    • 11.8.2 Siemens Healthcare Lateral Flow Rapid Testing Product Offered
    • 11.8.3 Siemens Healthcare Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Siemens Healthcare Main Business Overview
    • 11.8.5 Siemens Healthcare Latest Developments
  • 11.9 BD
    • 11.9.1 BD Company Information
    • 11.9.2 BD Lateral Flow Rapid Testing Product Offered
    • 11.9.3 BD Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 BD Main Business Overview
    • 11.9.5 BD Latest Developments
  • 11.10 R-Biopharma
    • 11.10.1 R-Biopharma Company Information
    • 11.10.2 R-Biopharma Lateral Flow Rapid Testing Product Offered
    • 11.10.3 R-Biopharma Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 R-Biopharma Main Business Overview
    • 11.10.5 R-Biopharma Latest Developments
  • 11.11 Cell Biolabs
    • 11.11.1 Cell Biolabs Company Information
    • 11.11.2 Cell Biolabs Lateral Flow Rapid Testing Product Offered
    • 11.11.3 Cell Biolabs Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Cell Biolabs Main Business Overview
    • 11.11.5 Cell Biolabs Latest Developments
  • 11.12 BioMerieux
    • 11.12.1 BioMerieux Company Information
    • 11.12.2 BioMerieux Lateral Flow Rapid Testing Product Offered
    • 11.12.3 BioMerieux Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 BioMerieux Main Business Overview
    • 11.12.5 BioMerieux Latest Developments
  • 11.13 Merck
    • 11.13.1 Merck Company Information
    • 11.13.2 Merck Lateral Flow Rapid Testing Product Offered
    • 11.13.3 Merck Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Merck Main Business Overview
    • 11.13.5 Merck Latest Developments
  • 11.14 Qiagen
    • 11.14.1 Qiagen Company Information
    • 11.14.2 Qiagen Lateral Flow Rapid Testing Product Offered
    • 11.14.3 Qiagen Lateral Flow Rapid Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Qiagen Main Business Overview
    • 11.14.5 Qiagen Latest Developments

12 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Lateral Flow Rapid Testing will have significant change from previous year. According to our (LP Information) latest study, the global Lateral Flow Rapid Testing market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Lateral Flow Rapid Testing market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Lateral Flow Rapid Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lateral Flow Rapid Testing market, reaching US$ million by the year 2028. As for the Europe Lateral Flow Rapid Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Lateral Flow Rapid Testing players cover Mologic, Thermo Fisher Scientific, Bio-Rad Laboratories, and Svar Life Science, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Lateral Flow Rapid Testing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Sandwich Immunoassay
Competitive Immunoassay

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals
Specialty Clinics
Diagnostic Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Mologic
Thermo Fisher Scientific
Bio-Rad Laboratories
Svar Life Science
Abbott Laboratories
Roche
Danaher
Siemens Healthcare
BD
R-Biopharma
Cell Biolabs
BioMerieux
Merck
Qiagen
Buy now